Vicebio

Developer of vaccines to treat viral infectious diseases

placeLondon, England, United Kingdom calendar_todayFounded 2019 groups4 employees language vicebio.com

Registered entities

Innovation

2 patent families — focus: Human necessities; filing pace active. Cited 67 times.

YearFilings
20262

Investor mix

5 investors on record; lead investors include TCG Crossover.

Investor typeCountShare
Venture capital480%
Accelerator & incubator120%
Coming soon